The AACR-Genmab Non-Hodgkin B-cell Lymphoma Research Fellowship represents a joint effort to encourage and support postdoctoral or clinical research fellows to conduct non-Hodgkin B-cell lymphoma research and to establish a successful career path in this field. The research proposed for funding may be basic, translational, clinical, or epidemiological in nature and must have direct applicability and relevance to non-Hodgkin B-cell lymphoma. This fellowship especially encourages applications for projects that will advance our knowledge and practice for treating non-Hodgkin B-cell lymphoma with, but not limited to, the following:
• Antibody-based therapeutics (e.g. monoclonal antibodies, antibody drug conjugates, cell engagers, etc.)
• Cell therapies
• Other Immunomodulators
This fellowship provides a two-year grant of $120,000 to support the salary and benefits of the fellow while working on mentored non-Hodgkin B-cell lymphoma research. A partial amount of funds may be designated for non-personnel expenses, such as research/laboratory supplies, equipment, publication charges for manuscripts that pertain directly to the funded project, and other research expenses. Indirect costs are not permitted.
Deadline: May 19, 2022